J. Wass

发表

Prevalence of pituitary adenomas: a community‐based, cross‐sectional study in Banbury (Oxfordshire, UK)

Alberto Fernández, N. Karavitaki, J. Wass, 2010, Clinical endocrinology.

Relative value of computed tomography scanning and venous sampling in establishing the cause of primary hyperaldosteronism.

R. Reznek, J. Goldin, D. Lowe, 1996, European journal of endocrinology.

60 YEARS OF NEUROENDOCRINOLOGY: Acromegaly.

J. Wass, C. Capatina, 2015, The Journal of endocrinology.

60 YEARS OF NEUROENDOCRINOLOGY: Acromegaly.

J. Wass, C. Capatina, 2015, The Journal of endocrinology.

A consensus on the diagnosis and treatment of acromegaly complications

P. Chanson, F. Casanueva, S. Melmed, 2012, Pituitary.

GROWTH-HORMONE-RELEASING FACTOR IN GROWTH HORMONE DEFICIENCY: DEMONSTRATION OF A HYPOTHALAMIC DEFECT IN GROWTH HORMONE RELEASE

A. Grossman, M. Savage, D. Coy, 1983, The Lancet.

Reduction of elevated IGF-1 levels in coincident amyotrophic lateral sclerosis and acromegaly

M. Turner, K. Talbot, J. Wass, 2010, Amyotrophic lateral sclerosis : official publication of the World Federation of Neurology Research Group on Motor Neuron Diseases.

Pituitary adenomas

J. Wass, A. Pal, L. Leaver, 2019, BMJ.

Nonfunctioning pituitary adenomas: the Oxford experience

N. Karavitaki, J. Wass, 2009, Nature Reviews Endocrinology.

When to discontinue treatment of prolactinoma?

J. Wass, 2006, Nature Clinical Practice Endocrinology &Metabolism.

Criteria for cure of acromegaly: a consensus statement.

F. Casanueva, S. Melmed, L. Frohman, 2000, The Journal of clinical endocrinology and metabolism.

Radiation-induced hypopituitarism.

M. Brada, Alberto Fernández, N. Karavitaki, 2009, Endocrine-related cancer.

Multiple endocrine neoplasia: spectrum of radiologic appearances and discussion of a multitechnique imaging approach.

F. Gleeson, A. Scarsbrook, R. Thakker, 2006, Radiographics : a review publication of the Radiological Society of North America, Inc.

The role of growth hormone in diabetes mellitus.

S. Amiel, J. Holly, J. Wass, 1988, The Journal of endocrinology.

Cell Biology International Reports, Vol. 5, No. 5, May 1987 Chemotactic Factor-Induced Adherence of Tumor Cells

P. Ward, J. Varani, J. Wass, 2003 .

Chemotactic factor-induced adherence of tumor cells.

P. Ward, J. Varani, J. Wass, 1981, Cell biology international reports.

Size increase induced in Walker ascites cells by chemotactic factors.

P. Ward, J. Varani, J. Wass, 1980, Cancer letters.

Growth of three established cell lines on glass microcarriers

M. Dame, J. Wass, James Carani, 1983, Biotechnology and bioengineering.

Autoimmune thyroid syndrome in women with Turner's syndrome—the association with karyotype

G. Conway, J. Wass, M. Elsheikh, 2001 .

Hypertension is a major risk factor for aortic root dilatation in women with Turner's syndrome

B. Casadei, G. Conway, J. Wass, 2001, Clinical endocrinology.

Hormone replacement therapy may improve hepatic function in women with Turner's syndrome

G. Conway, J. Wass, H. Hodgson, 2001, Clinical endocrinology.

Improvement in mood and fatigue after dehydroepiandrosterone replacement in Addison's disease in a randomized, double blind trial.

F. Huppert, A. Prevost, V. Chatterjee, 2000, The Journal of clinical endocrinology and metabolism.

Osteoclast differentiation from circulating mononuclear precursors in Paget's disease is hypersensitive to 1,25-dihydroxyvitamin D(3) and RANKL.

N. Athanasou, J. Wass, S. Neale, 2000, Bone.

Parathyroid adenomas and cardiovascular risk.

N. García de la Torre, J. Wass, H. Turner, 2003, Endocrine-related cancer.

Radiotherapy in acromegaly: a protagonists viewpoint

J. Wass, 2003, Clinical endocrinology.

Pituitary tumours in the elderly.

J. Wass, H. Turner, 1997, Bailliere's clinical endocrinology and metabolism.

Obesity and polycystic ovary syndrome

M. McCarthy, S. Franks, T. Barber, 2006, Clinical endocrinology.

Metabolic characteristics of women with polycystic ovaries and oligo‐amenorrhoea but normal androgen levels: implications for the management of polycystic ovary syndrome

M. McCarthy, S. Franks, T. Barber, 2007, Clinical endocrinology.

Global adiposity rather than abnormal regional fat distribution characterizes women with polycystic ovary syndrome.

M. McCarthy, F. Karpe, S. Franks, 2008, The Journal of clinical endocrinology and metabolism.

Association of variants in the fat mass and obesity associated (FTO) gene with polycystic ovary syndrome

P. Elliott, M. McCarthy, C. Lindgren, 2008, Diabetologia.

The Therapeutic Value of Somatostatin and Its Analogues

J. Wass, J. Bevan, S. Farooqi, 1999, Pituitary.

Chlorpropamide alcohol flush and circulating met-enkephalin: a positive link.

J. Wass, E. Cooke, S. Bowcock, 1981, British medical journal.

Valvular heart disease and the use of cabergoline for the treatment of prolactinoma

C. Szmigielski, H. Becher, N. Herring, 2009, Clinical endocrinology.

Assessment of p27 (cyclin‐dependent kinase inhibitor 1B) and aryl hydrocarbon receptor‐interacting protein (AIP) genes in multiple endocrine neoplasia (MEN1) syndrome patients without any detectable MEN1 gene mutations

R. Quinton, M. Korbonits, S. Akker, 2009, Clinical endocrinology.

Treatment of advanced prostatic cancer with buserelin, an analogue of gonadotrophin releasing hormone.

J. Wass, H. Whitfield, J. Malpas, 1983, British journal of urology.

Treatment with gonadotrophin releasing hormone analogue in advanced prostatic cancer.

J. Wass, H. Whitfield, J. Malpas, 1983, British medical journal.

The effects of short-term administration of two low doses versus the standard GH replacement dose on insulin sensitivity and fasting glucose levels in young healthy adults.

P. Gluckman, D. Dunger, K. Ong, 2002, The Journal of clinical endocrinology and metabolism.

Unexplained severe hypoglycaemia in hospital: a difficult diagnostic challenge.

J. Wass, A. Vale, J. Walker, 2009, British journal of clinical pharmacology.

A Consensus on the Diagnosis and Treatment of Acromegaly Comorbidities: An Update.

F. Casanueva, S. Melmed, F. Keleştimur, 2020, The Journal of clinical endocrinology and metabolism.

A Consensus Statement on acromegaly therapeutic outcomes

P. Chanson, F. Casanueva, S. Melmed, 2018, Nature Reviews Endocrinology.

Guidance for the prevention and emergency management of adult patients with adrenal insufficiency.

J. Dean, J. Wass, W. Arlt, 2020, Clinical medicine.

Growth hormone in the treatment of dilated cardiomyopathy.

J. Wass, H. Turner, Wass Ja, 1996, The New England journal of medicine.

Hormone Replacement Therapy and Cardiovascular Disease in Women

J. Wass, M. Sathiavageeswaran, 2002 .

Wide variation in surgical outcomes for acromegaly in the UK

M. Carson, J. Wass, P. Trainer, 2008, Clinical endocrinology.

Guidelines for acromegaly management.

P. Chanson, E. Laws, F. Casanueva, 2002, The Journal of clinical endocrinology and metabolism.

Long-term effects of radiotherapy for acromegaly.

J. Wass, 1996, Metabolism: clinical and experimental.

Preoperative medical treatment in Cushing's syndrome: frequency of use and its impact on postoperative assessment: data from ERCUSYN.

P. Chanson, A. Tabarin, M. Tóth, 2018, European journal of endocrinology.

Pituitary imaging using a labelled somatostatin analogue in acromegaly

S. Mather, A. Grossman, J. Bomanji, 1992, Clinical endocrinology.

Medical problems in adult women with Turner's syndrome.

G. Conway, J. Wass, M. Elsheikh, 1999, Annals of medicine.

YEARS OF NEUROENDOCRINOLOGY Acromegaly

J. Wass, C. Capatina, 2015 .

Clinical Endocrine Oncology

I. Hay, J. Wass, 1997 .

Lymphoplasmacytoid lymphoma presenting as severe osteoporosis

J. Wass, T. Littlewood, C. Hatton, 2002, American journal of hematology.

Suggestive Linkage of the Parathyroid Receptor Type 1 to Osteoporosis

J. Sinsheimer, J. Bell, E. Duncan, 1999, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

What's new in... Endocrinology

J. Wass, V. Toh, 2001 .

Primary medical therapy for acromegaly: an open, prospective, multicenter study of the effects of subcutaneous and intramuscular slow-release octreotide on growth hormone, insulin-like growth factor-I, and tumor size.

P M Stewart, J M Wardlaw, P E Harris, 2002, The Journal of clinical endocrinology and metabolism.

Debulking of pituitary adenomas improves hormonal control of acromegaly by somatostatin analogues.

J. Wass, 2005, European journal of endocrinology.

The value of an acute octreotide suppression test in predicting long‐term responses to depot somatostatin analogues in patients with active acromegaly

N. Karavitaki, J. Wass, H. Turner, 2005, Clinical endocrinology.

Gallstones during octreotide therapy.

J. Wass, R. Dowling, G. Murphy, 1992, Metabolism: clinical and experimental.

ARE THERE GENETIC DETERMINANTS FOR THE GLUCOSE INTOLERANCE OF ACROMEGALY?

J. Wass, G. Besser, N. Jowett, 1985, Clinical endocrinology.

Patterns of ovarian morphology in polycystic ovary syndrome: a study utilising magnetic resonance imaging

M. McCarthy, S. Franks, T. Barber, 2010, European Radiology.

Serum levels of retinol-binding protein 4 and adiponectin in women with polycystic ovary syndrome: associations with visceral fat but no evidence for fat mass-independent effects on pathogenesis in this condition.

M. McCarthy, A. Vidal-Puig, S. Franks, 2008, The Journal of clinical endocrinology and metabolism.

Histocompatibility leucocyte antigens and closely linked immunomodulatory genes in autoimmune thyroid disease

J. Bell, S. Marshall, K. Welsh, 2001, Clinical endocrinology.

Ghrelin levels are suppressed and show a blunted response to oral glucose in women with polycystic ovary syndrome.

M. McCarthy, F. Casanueva, F. Karpe, 2008, European journal of endocrinology.

Expanding boundaries of endocrinology.

J. Wass, A. Lumb, 2010, Clinical medicine.

GH replacement in patients with non‐functioning pituitary adenoma (NFA) treated solely by surgery is not associated with increased risk of tumour recurrence

N. Karavitaki, J. Wass, J. Arnold, 2009, Clinical endocrinology.

GH replacement does not increase the risk of recurrence in patients with craniopharyngioma

J. Warner, N. Karavitaki, J. Wass, 2006, Clinical endocrinology.

Rathke’s cleft cysts

N. Karavitaki, J. Wass, O. Ansorge, 2012, Clinical endocrinology.

Volume-Outcome Associations for Parathyroid Surgery in England: Analysis of an Administrative Data Set for the Getting It Right First Time Program.

J. Wass, A. Navaratnam, W. Gray, 2022, JAMA surgery.

Volume-outcome relationship for adrenalectomy: analysis of an administrative dataset for the Getting It Right First Time Programme.

T. Briggs, J. Wass, W. Gray, 2021, The British journal of surgery.

Diagnosis and treatment of acromegaly complications

P. Chanson, F. Casanueva, M. Vance, 2003, Journal of endocrinological investigation.

Autoimmune thyroid syndrome in women with Turner's syndrome--the association with karyotype.

J. Wass, M. Elsheikh, G. Conway, 2001, Clinical endocrinology.

AUTOIMMUNE CRANIAL DIABETES INSIPIDUS: ITS ASSOCIATION WITH OTHER ENDOCRINE DISEASES AND WITH HISTIOCYTOSIS X

W. Scherbaum, D. Doniach, G. Bottazzo, 1986, Clinical endocrinology.

Digital Vasospasm with Bromocriptine

M. Thorner, J. Wass, G. Besser, 1976, The Lancet.

PLEUROPULMONARY SHADOWS ON BROMOCRIPTINE

J. Wass, G. Besser, 1981, The Lancet.

The effect of hormone replacement therapy on cardiovascular hemodynamics in women with Turner's syndrome.

G. Conway, J. Wass, M. Elsheikh, 2000, The Journal of clinical endocrinology and metabolism.

Second brain tumour after treatment for pituitary adenoma.

A. Grossman, J. Wass, N. Plowman, 1992, BMJ.

Post-operative Replacement and Assessment of HPA Axis Recovery in Cushing’s Syndrome

N. Karavitaki, J. Wass, Sibylle Kohler, 2010 .

Pheochromocytoma Is Characterized by Catecholamine-Mediated Myocarditis, Focal and Diffuse Myocardial Fibrosis, and Myocardial Dysfunction.

M. Robson, J. Francis, S. Piechnik, 2016, Journal of the American College of Cardiology.

University of Birmingham Pheochromocytoma is Characterized By Catecholamine Myocarditis, Focal and Diffuse Fibrosis, and Persistent Subclinical Systolic and Diastolic Dysfunction

M. Robson, J. Francis, S. Piechnik, 2016 .

Pheochromocytoma is Characterized By Catecholamine Myocarditis, Focal and Diffuse Fibrosis, and Persistent Subclinical Systolic and Diastolic Dysfunction

M. Robson, J. Francis, S. Piechnik, 2016 .

Increased insulin sensitivity in young, growth hormone deficient children

D. Dunger, K. Ong, J. Wass, 2001, Clinical endocrinology.

The regulation of insulin‐like growth factor binding protein (IGFBP)‐1 during prolonged fasting

A. Cotterill, J. Wass, J. Holly, 1993, Clinical endocrinology.

Effect of the dopamine agonist, lergotrile mesylate, on circulating anterior pituitary hormones in man.

S. M. Ryan, M. Thorner, J. Wass, 1978, The Journal of clinical endocrinology and metabolism.

THE EFFECT OF LISURIDE HYDROGEN MALEATE, AN ERGOT DERIVATIVE ON ANTERIOR PITUITARY HORMONE SECRETION IN MAN

G. Delitala, W. Stubbs, J. Wass, 1979, Clinical endocrinology.

CSF AND PLASMA SOMATOSTATIN LEVELS IN ACROMEGALY

J. Wass, G. Besser, L. Rees, 1980, Clinical endocrinology.

Actual and Potential Clinical Uses of IGF-1

J. Wass, 1993, The Journal of pediatric endocrinology.

CORTICOTROPHIN RELEASING FACTOR: RESPONSES IN NORMAL SUBJECTS AND PATIENTS WITH DISORDERS OF THE HYPOTHALAMUS AND PITUITARY

A. Grossman, A. Schally, D. Coy, 1984, Clinical endocrinology.

Increased 5 alpha-reductase activity and adrenocortical drive in women with polycystic ovary syndrome.

M. McCarthy, S. Franks, T. Barber, 2009, The Journal of clinical endocrinology and metabolism.

THE GROWTH HORMONE INDEPENDENT INSULIN‐LIKE GROWTH FACTOR‐I BINDING PROTEIN BP‐28 IS ASSOCIATED WITH SERUM INSULIN‐LIKE GROWTH FACTOR‐I INHIBITORY BIOACTIVITY IN ADOLESCENT INSULIN‐DEPENDENT DIABETICS

D. Dunger, M. Preece, J. Wass, 1990, Clinical endocrinology.

IMMUNOREACTIVE SOMATOSTATIN CHANGES DURING INSULIN‐INDUCED HYPOGLYCAEMIA AND OPERATIVE STRESS IN MAN

V. Marks, J. Wass, A. Dawson, 1980, Clinical endocrinology.

Octreotide increases the proportions of arachidonic acid‐rich phospholipids in gall‐bladder bile

S. Pereira, J. Wass, R. Dowling, 2001, Alimentary pharmacology & therapeutics.

An audit of the insulin tolerance test in adult subjects in an acute investigation unit over one year

A. Grossman, J. Wass, G. Besser, 1994, Clinical endocrinology.

High dose androgen therapy in male pseudohermaphroditism due to 5 alpha-reductase deficiency and disorders of the androgen receptor.

J. Wilson, J. Griffin, M. Savage, 1984, The Journal of clinical investigation.

Insulin-like growth factors; autocrine, paracrine or endocrine? New perspectives of the somatomedin hypothesis in the light of recent developments.

J. Holly, J. Wass, 1989, The Journal of endocrinology.

IMMUNOREACTIVE HUMAN CHORIONIC GONADOTROPHIN FROM THE CYST FLUID AND CSF OF PATIENTS WITH CRANIOPHARYNGIOMA

T. Chard, D. Lowe, P. Coates, 1988, Clinical Endocrinology.

THE EFFECT OF DOPAMINE AGONIST THERAPY ON LARGE FUNCTIONLESS PITUITARY TUMOURS

A. Grossman, R. Ross, J. Wass, 1985, Clinical endocrinology.

Response of circulating immunoreactive somatostatin to nutritional stimuli in normal subjects

J. Wass, G. Besser, L. Rees, 1981 .

MOLECULAR FORMS OF SOMATOSTATIN IN NORMAL SUBJECTS AND IN PATIENTS WITH PANCREATIC SOMATOSTATINOMA

V. Marks, J. Wass, A. Dawson, 1980, Clinical endocrinology.

Pituitary, adrenal and thyroid incidentalomas

J. Wass, J. Byrne, H. Turner, 1998 .

RELATIONSHIP BETWEEN THE PUBERTAL FALL INSEX HORMONE BINDING GLOBULIN AND INSULIN‐LIKE GROWTH FACTOR BINDING PROTEIN‐I. A SYNCHRONIZED APPROACH TO PUBERTAL DEVELOPMENT?

D. Dunger, T. Chard, M. Savage, 1989, Clinical endocrinology.

Hormone Replacement Therapy with Testosterone

J. Wass, M. Sathiavageeswaran, 2002 .

Prolonged large bowel transit increases serum deoxycholic acid: a risk factor for octreotide induced gallstones

M. Veysey, P. Jenkins, J. Wass, 1999, Gut.

Role of intestinal transit in the pathogenesis of gallbladder stones.

M. Veysey, S. Pereira, J. Wass, 1997, Canadian journal of gastroenterology = Journal canadien de gastroenterologie.

Octreotide induced prolongation of colonic transit increases faecal anaerobic bacteria, bile acid metabolising enzymes, and serum deoxycholic acid in patients with acromegaly

M. Veysey, D. Russell-Jones, J. Wass, 2005, Gut.

A case of macroprolactinoma encasing an internal carotid artery aneurysm, presenting as pituitary apoplexy

J. Wass, J. Byrne, S. Cudlip, 2007, Pituitary.

Insulin‐like Growth Factor Binding Protein‐1 Levels in Diabetic Adolescents and their Relationship to Metabolic Control

D. Dunger, T. Chard, J. Edge, 1990, Diabetic medicine : a journal of the British Diabetic Association.

THE GROWTH HORMONE RELEASING HORMONE (GHRH) RESPONSE TO A MIXED MEAL IS BLUNTED IN YOUNG ADULTS WITH INSULIN‐DEPENDENT DIABETES MELLITUS WHEREAS THE SOMATOSTATIN RESPONSE IS NORMAL

D. Dunger, J. Edge, J. Wass, 1990, Clinical endocrinology.

ORCADIAN VARIATION OF GH‐INDEPENDENT IGF‐BINDING PROTEIN IN DIABETES MELLITUS AND ITS RELATIONSHIP TO INSULIN. A NEW ROLE FOR INSULIN?

T. Chard, J. Edge, S. Amiel, 1988, Clinical endocrinology.

CIRCULATING SOMATOSTATIN AFTER FOOD AND GLUCOSE IN MAN

J. Wass, A. Dawson, G. Besser, 1980, Clinical endocrinology.

The Pathology of Median Neuropathy in Acromegaly

R. Reznek, S. Sohaib, S. Akker, 2000, Annals of Internal Medicine.

Non-adenomatous pituitary tumours.

N. Karavitaki, J. Wass, 2009, Best practice & research. Clinical endocrinology & metabolism.

Multidisciplinary management of acromegaly: A consensus

P. Chanson, A. Mamelak, F. Casanueva, 2020, Reviews in Endocrine and Metabolic Disorders.

Control of growth hormone and IGF1 in patients with acromegaly in the UK: responses to medical treatment with somatostatin analogues and dopamine agonists

J. Wass, T. Howlett, P. Trainer, 2013, Clinical endocrinology.

The value of the oral glucose tolerance test, random serum growth hormone and mean growth hormone levels in assessing the postoperative outcome of patients with acromegaly

N. Karavitaki, J. Wass, V. Fazal-Sanderson, 2009, Clinical endocrinology.

Guidelines of the Pituitary Society for the diagnosis and management of prolactinomas

P. Cappabianca, E. Laws, R. Fahlbusch, 2006, Clinical endocrinology.

CONSENSUS Guidelines for Acromegaly Management

P. Chanson, F. Casanueva, M. Vance, 2002 .

State-of-the-art strategies for the diagnosis and management of acromegaly

S. Melmed, A. Klibanski, D. Clemmons, 2001 .

Modern approaches to treating acromegaly.

J. Wass, H. Turner, 2000, QJM : monthly journal of the Association of Physicians.

Investigation protocol: Acromegaly and its investigation

E. Duncan, J. Wass, J. Wass, 1999, Clinical endocrinology.

Long-term treatment of acromegaly with bromocriptine.

A. Mason, M. Thorner, J. Wass, 1977, British medical journal.

Inhibition of interleukin 2 production by factors released from tumor cells.

P. Hersey, J. Wass, W. McCarthy, 1983, Journal of immunology.

Whole-exome sequencing studies of nonfunctioning pituitary adenomas.

G. McVean, D. Buck, Lorna Gregory, 2013, The Journal of clinical endocrinology and metabolism.

Characterization by high-performance liquid chromatography of circulating growth hormone-releasing factors in normal subjects.

J. Wass, G. Besser, L. Rees, 1986, The Journal of endocrinology.

Circulating growth hormone releasing factor concentrations in normal subjects and patients with acromegaly.

J. Wass, G. Besser, N. Lytras, 1984, British medical journal.

A comparison of the insulin tolerance/glucagon test with the short ACTH stimulation test in the assessment of the hypothalamo‐pituitary‐adrenal axis in the early post‐operative period after hypophysectomy

J. J. Mukherjee, A. Grossman, G. Kaltsas, 1997, Clinical endocrinology.

Cytokine gene polymorphisms in autoimmune thyroid disease.

J. Bell, S. Marshall, K. Welsh, 2000, The Journal of clinical endocrinology and metabolism.

Respiratory muscle strength in Cushing's syndrome.

M. Polkey, G. Mills, J. Moxham, 1999, American journal of respiratory and critical care medicine.

Osteoclast formation from circulating precursors in osteoporosis

M. Brown, N. Athanasou, J. Wass, 2003, Scandinavian journal of rheumatology.

Reversible respiratory muscle weakness in hyperthyroidism.

J. Wass, A. Mier, M. Green, 1989, The American review of respiratory disease.

Respiratory muscle weakness in Addison's disease.

J. Wass, A. Mier, C. Laroche, 1988, BMJ.

The role of bile composition and physical chemistry in the pathogenesis of octreotide-associated gallbladder stones.

J. Wass, R. Dowling, G. Murphy, 1994, Gastroenterology.

P. Chanson, A. Tabarin, M. Tóth, 2018, Clinical endocrinology.

A. Harris, M. Esiri, Z. Nagy, 2000 .

Somatostatin analogs modulate AIP in somatotroph adenomas: the role of the ZAC1 pathway.

M. Korbonits, S. Schulz, A. Grossman, 2012, The Journal of clinical endocrinology and metabolism.

The rapid diagnosis of sensitivity or resistance to dopamine agonists with depot bromocriptine.

A. Grossman, J. Wass, M. Besser, 1987, Acta endocrinologica.

DEPOT‐BROMOCRIPTINE TREATMENT FOR PROLACTINOMAS AND ACROMEGALY

A. Grossman, R. Ross, J. Wass, 1986, Clinical endocrinology.

COMPARISON OF THE CLINICAL ACTIVITY OF MESULERGINE AND PERGOLIDE IN THE TREATMENT OF HYPERPROLACTINAEMIA

A. Grossman, J. Wass, G. Besser, 1985, Clinical endocrinology.

Psychotic reactions during treatment of pituitary tumours with dopamine agonists.

J. Wass, P. Drury, G. Besser, 1984, British medical journal.

REDUCTION OF PITUITARY-TUMOUR SIZE IN PATIENTS WITH PROLACTINOMAS AND ACROMEGALY TREATED WITH BROMOCRIPTINE WITH OR WITHOUT RADIOTHERAPY

M. Thorner, J. Wass, J. Dacie, 1979, The Lancet.

Asymptomatic hyperparathyroidism – need for multicentre studies

J. Wass, R. Mihai, G. Sadler, 2007, Clinical endocrinology.

Absence of mutations in the MEN2A region of the ret proto‐oncogene in non‐MEN 2A phaeochromocytomas

S. Chew, R. Ross, A. Clark, 1995, Clinical endocrinology.

Late Effects of Cancer Treatment

R. Ross, J. Wass, Georg Brabant Steve Ball Andy Toogood, 2017 .

AN ASSESSMENT OF GLUCOSE INTOLERANCE IN ACROMEGALY AND ITS RESPONSE TO MEDICAL TREATMENT

G. Bottazzo, J. Wass, G. Besser, 1980, Clinical endocrinology.

Oncological Complications of Excess GH in Acromegaly

F. Casanueva, J. Wass, S. Webb, 2004, Pituitary.

11 The treatment of acromegaly

E. Laws, R. Randall, J. Wass, 1986 .

A single sleeping midnight cortisol has 100% sensitivity for the diagnosis of Cushing's syndrome

A. Grossman, J. Newell-Price, J. Wass, 1995, Clinical endocrinology.

Roles of gall bladder emptying and intestinal transit in the pathogenesis of octreotide induced gall bladder stones.

M. Veysey, S. Pereira, P. Jenkins, 1996, Gut.

Diagnostic tests for Cushing's syndrome differ from published guidelines: data from ERCUSYN.

P. Chanson, A. Tabarin, M. Tóth, 2017, European journal of endocrinology.

Epidemiology of acromegaly: review of population studies

N. Karavitaki, J. Wass, Aikaterini Lavrentaki, 2016, Pituitary.

RISK FACTOR FOR MYOCARDIAL INFARCTION IN TRANSURETHRAL RESECTION OF PROSTATE?

P. Kendall‐Taylor, J. Wass, G. Besser, 1989, The Lancet.

Undetectable postoperative cortisol does not always predict long‐term remission in Cushing’s disease: a single centre audit *

J. Wass, H. Turner, C. Adams, 2002, Clinical endocrinology.

Bisphosphonate treatment of aggressive primary, recurrent and metastatic Giant Cell Tumour of Bone

P. Picci, P. Hogendoorn, M. Balke, 2010, BMC Cancer.

Imaging islet cell tumours.

R. Reznek, J. Wass, J. Dacie, 1994, Clinical radiology.

The long-term outcome after adrenalectomy and prophylactic pituitary radiotherapy in adrenocorticotropin-dependent Cushing's syndrome.

A. Grossman, P. Jenkins, J. Wass, 1995, The Journal of clinical endocrinology and metabolism.

Megavoltage pituitary irradiation in the management of prolactinomas: long‐term follow‐up

A. Grossman, J. Wass, G. Besser, 1991, Clinical endocrinology.

The Therapeutic Modulation of Growth Hormone Release

R. Ross, J. Wass, 1989 .

Suppression of endogenous insulin secretion regulates the rapid rise of insulin‐like growth factor binding protein (IGFBP)‐1 levels following acute hypoglycaemia

S. Amiel, J. Holly, A. Cotterill, 1993, Clinical endocrinology.

Evidence for the effectiveness of radiotherapy in the treatment of acromegaly.

J. Wass, 1997, The Journal of endocrinology.

Circulating immunoreactive somatostatin in man. Effect of age, pregnancy, growth hormone deficiency and achlorhydria.

J. Wass, J. Serrano, C. Pavia, 1985, Acta endocrinologica.

Cytokines modulate the sensitivity of human fibroblasts to stimulation with insulin-like growth factor-I (IGF-I) by altering endogenous IGF-binding protein production.

J. Holly, J. Wass, M. Yateman, 1993, The Journal of endocrinology.

The induction of specific proteases for insulin-like growth factor-binding proteins following major heart surgery.

J. Holly, A. Cotterill, J. Wass, 1992, The Journal of endocrinology.

Short report: plasma somatostatin concentrations in the irritable bowel syndrome

M. Farthing, J. Wass, M. Farthing, 1991, Alimentary Pharmacology and Therapeutics.

Intestinal control of gastric function in the calf: the relationship of neural and endocrine factors

J. Wass, F. Bell, A. Green, 1981, The Journal of physiology.

Hypopituitarism: growth hormone and corticotropin deficiency.

J. Wass, C. Capatina, 2015, Endocrinology and metabolism clinics of North America.

Expression of guanylyl cyclase-B (GC-B/NPR2) receptors in normal human fetal pituitaries and human pituitary adenomas implicates a role for C-type natriuretic peptide.

I. McGonnell, M. Korbonits, A. Mcneilly, 2012, Endocrine-Related Cancer.

Proteolytic modification of insulin-like growth factor-binding proteins: comparison of conditioned media from human cell lines, circulating proteases and characterized enzymes.

J. Holly, J. Wass, V. Macaulay, 1993, The Journal of endocrinology.

Composition of gall bladder stones associated with octreotide: response to oral ursodeoxycholic acid.

S. Pereira, J. Wass, R. Dowling, 1995, Gut.

Gallstones during octreotide therapy.

J. Wass, R. Dowling, G. Murphy, 1993, Digestion.

Correlation of endogenous somatostatin, gastric inhibitory polypeptide, glucagon and insulin with gastric function in the conscious calf.

V. Marks, J. Wass, L. Morgan, 1981, The Journal of endocrinology.

Effect of octreotide on gall stone prevalence and gall bladder motility in acromegaly.

R. Trembath, J. Wass, P. Fairclough, 1993, Gut.

Responses of normal and malignant cells to collagen, collagen-derived peptides and the C5-related tumor cell chemotactic peptide.

F. Orr, P. Ward, J. Varani, 1981, Cell differentiation.

Malignant prolactinoma with extracranial metastases: a report of three cases

John D. Walker, P. Sönksen, D. Lowe, 1993, Clinical endocrinology.

INSULIN‐LIKE GROWTH FACTOR BINDING PROTEINS IN FOLLICULAR FLUID FROM NORMAL DOMINANT AND COHORT FOLLICLES, POLYCYSTIC AND MULTICYSTIC OVARIES

T. Chard, J. Holly, J. Wass, 1990, Clinical Endocrinology.

Sex Hormone Binding Globulin Levels in Adolescent Subjects with Diabetes Mellitus

D. Dunger, M. Savage, J. Holly, 1992, Diabetic medicine : a journal of the British Diabetic Association.

Management of endocrine disease: pituitary tumour apoplexy.

W. Inder, N. Karavitaki, J. Wass, 2015, European journal of endocrinology.

Pituitary tumour apoplexy

W. Inder, N. Karavitaki, J. Wass, 2015 .

Prevalence of Helicobacter pylori in acromegalic patients during treatment with octreotide

M. Farthing, J. Wass, G. Besser, 1995, Clinical endocrinology.

Prevalence of gastritis in patients with acromegaly: untreated and during treatment with octreotide

D. Lowe, J. Wass, P. Fairclough, 1992, Clinical endocrinology.

When to consider thyroid dysfunction in the neurology clinic

M. Turner, J. Wass, N. Mistry, 2009, Practical Neurology.

Examination of the Thyroid Gland and Thyroid Status

J. Wass, Vaishnavee Sreeharan, 2007 .

Gender- and age-related differences in osteoclast formation from circulating precursors.

N. Athanasou, J. Wass, S. Neale, 2002, The Journal of endocrinology.

Insulin-like growth factor binding proteins (IGFBPs) in acromegaly.

J. Holly, A. Cotterill, J. Wass, 1991, Growth regulation.

PROLACTINOMAS PRESENTING AS PRIMARY AMENORRHOEA AND DELAYED OR ARRESTED PUBERTY: RESPONSE TO MEDICAL THERAPY

A. Grossman, J. Wass, G. Besser, 1989, Clinical endocrinology.

Classical pituitary apoplexy: clinical features, management and outcome

H. Randeva, M. Esiri, J. Wass, 1999, Clinical endocrinology.

Treatment of pituitary tumors

N. Karavitaki, J. Wass, S. Cudlip, 2005, Endocrine.

Craniopharyngiomas in children and adults: systematic analysis of 121 cases with long‐term follow‐up

J. Warner, C. Brufani, N. Karavitaki, 2005, Clinical endocrinology.

The Use of Dopamine Agonists in the Management of Acromegaly

J. Wass, G. Besser, 1987 .

Prevention of Adrenal Crisis: Cortisol Responses to Major Stress Compared to Stress Dose Hydrocortisone Delivery

D. Annane, J. Lord, B. Keevil, 2020, Journal of Clinical Endocrinology and Metabolism.

Prevention of Adrenal Crisis: Cortisol Responses to Major Stress Compared to Stress Dose Hydrocortisone Delivery

D. Annane, J. Lord, B. Keevil, 2020, medRxiv.

Conventional pituitary irradiation is effective in lowering serum growth hormone and insulin-like growth factor-I in patients with acromegaly.

M. Carson, P. Jenkins, J. Wass, 2006, The Journal of clinical endocrinology and metabolism.

Comprar Oxford Textbook of Endocrinology and Diabetes 2Ed | Melanie C. Davies | 9780199235292 | Oxford University Press

S. Amiel, J. Wass, P. Stewart, 2011 .

UK guidelines for the management of pituitary apoplexy a rare but potentially fatal medical emergency

M. Vanderpump, J. Wass, C. Higgens, 2010, Emergency Medicine Journal.

Somatostatin Octapeptide in the Medical Treatment of Acromegaly

J. Wass, G. Besser, 1987 .

Somatostatin octapeptide (SMS 201-995) in the medical treatment of acromegaly.

J. Wass, G. Besser, N. Lytras, 1986, Scandinavian journal of gastroenterology. Supplement.

Octreotide

J. Wass, G. Besser, 2021, Reactions Weekly.

What is the natural history of nonoperated nonfunctioning pituitary adenomas?

N. Karavitaki, J. Wass, J. Byrne, 2007, Clinical endocrinology.

Do the limits of serum prolactin in disconnection hyperprolactinaemia need re‐definition? A study of 226 patients with histologically verified non‐functioning pituitary macroadenoma

N. Karavitaki, J. Wass, O. Ansorge, 2006, Clinical endocrinology.

Intracardiac metastases from neuroendocrine tumours

W. Drake, D. Lowe, A. Grossman, 1997, Clinical endocrinology.

The role of the aryl hydrocarbon receptor-interacting protein gene in familial and sporadic pituitary adenomas.

Julian R. E. Davis, D. Berney, R. Quinton, 2008, The Journal of clinical endocrinology and metabolism.

What is the natural history of nonoperated nonfunctioning pituitary adenomas?

N. Karavitaki, J. Wass, J. Byrne, 2008, Clinical endocrinology.

The Importance of Locating a Good Pituitary Surgeon

J. Wass, H. Turner, C. Adams, 1999, Pituitary.

Investigation of bone

J. Wass, H. Turner, 2009 .

Calcium and bone metabolism

J. Wass, H. Turner, K. Owen, 2014 .

Methoxyflurane anesthesia for Rana pipiens.

J. Wass, H. M. Kaplan, 1974, Laboratory animal science.

Consensus statement: medical management of acromegaly.

P. Chanson, E. Laws, F. Casanueva, 2005, European journal of endocrinology.

Axonal Transport of Neuropeptides in the Cervical Vagus Nerve of the Rat

J. Fahrenkrug, J. Wass, C. Lee, 1980, Journal of neurochemistry.

Turner's syndrome in adulthood.

D. Dunger, G. Conway, J. Wass, 2002, Endocrine reviews.

Acromegaly: an endocrine society clinical practice guideline.

E. Laws, M. Murad, S. Melmed, 2014, The Journal of clinical endocrinology and metabolism.

StatXact 4 for Windows

J. Wass, John A. Wass, 2000 .

hCGβ PRODUCING PINEAL CHORIOCARCINOMA

J. Wass, G. Besser, L. Rees, 1982 .

The induction of a specific protease for insulin-like growth factor binding protein-3 in the circulation during severe illness.

J. Holly, R. Ross, A. Cotterill, 1991, The Journal of endocrinology.

Diagnosis and treatment of hyperprolactinemia: an Endocrine Society clinical practice guideline.

Victor M Montori, Felipe F Casanueva, A. Hoffman, 2011, The Journal of clinical endocrinology and metabolism.

Practice Guideline Diagnosis and Treatment of Hyperprolactinemia : An Endocrine Society Clinical

A. Hoffman, V. Montori, F. Casanueva, 2011 .

Are Markers of Proliferation Valuable in the Histological Assessment of Pituitary Tumours?

J. Wass, H. Turner, 1999, Pituitary.

The chemotactic response of tumor cells. A model for cancer metastasis.

P A Ward, F. Orr, P. Ward, 1981, The American journal of pathology.

Characteristics of the chemotactic factor-mediated cell swelling response of tumor cells.

P. Ward, J. Varani, J. Wass, 1981, Journal of the National Cancer Institute.

Characterization of the molecular genetic pathology in patients with 11β‐hydroxylase deficiency

J. Connell, J. Wass, N. Krone, 2015, Clinical endocrinology.

Letter: Digital vasospasm with bromocriptine.

M. Thorner, J. Wass, G. Besser, 1976, Lancet.

Angiogenesis in endocrine tumors.

Adrian L Harris, A. Harris, S. Melmed, 2003, Endocrine reviews.

Angiogenesis in pituitary adenomas and the normal pituitary gland.

A. Harris, M. Esiri, Z. Nagy, 2000, The Journal of clinical endocrinology and metabolism.

Thyroid Screening During Early Pregnancy and the Need for Trimester Specific Reference Ranges: A Cross-Sectional Study in Lahore, Pakistan

S. Nasreen, J. Wass, Aleena Khan, 2019, Cureus.

Characterization of mutations in patients with multiple endocrine neoplasia type 1.

S. Forbes, B. Harding, C. Edwards, 1998, American journal of human genetics.

Gene deletion causing adrenal hypoplasia congenita and hypogonadotrophic hypogonadism

A. Walker, G. Matfin, R. Sheaves, 1994, Clinical endocrinology.

What are the markers of aggressiveness in prolactinomas? Changes in cell biology, extracellular matrix components, angiogenesis and genetics.

N. Karavitaki, J. Wass, O. Ansorge, 2007, European journal of endocrinology.

A genome-wide screen in 1119 relative pairs with autoimmune thyroid disease.

J. Connell, J. Franklyn, S. Gough, 2006, The Journal of clinical endocrinology and metabolism.

Outcome of Nonfunctioning Pituitary Adenomas That Regrow After Primary Treatment: A Study From Two Large UK Centers

James V. Byrne, Neil Gittoes, Niki Karavitaki, 2017, The Journal of clinical endocrinology and metabolism.

Clinical Biology of the Pituitary Adenoma

J. Bertherat, S. Melmed, M. Fleseriu, 2022, Endocrine reviews.

Angiogenesis and lymphangiogenesis in thyroid proliferative lesions: relationship to type and tumour behaviour.

J. Wass, H. Turner, N. G. de la Torre, 2004, Endocrine-related cancer.

Cyclin D1 (CCND1) genotype is associated with tumour grade in sporadic pituitary adenomas.

A. Grossman, W. Farrell, R. Clayton, 2001, Carcinogenesis.

Different patterns of allelic loss (loss of heterozygosity) in recurrent human pituitary tumors provide evidence for multiclonal origins.

M. Vanderpump, United Kingdom., W. Farrell, 2000, Clinical cancer research : an official journal of the American Association for Cancer Research.

Molecular Scanning of the Insulin Receptor Gene in Syndromes of Insulin Resistance

S. O’Rahilly, A. Boulton, A. Krook, 1994, Diabetes.

Trans-sphenoidal surgery for microprolactinoma: an acceptable alternative to dopamine agonists?

J. Wass, H. Turner, C. Adams, 1999, European journal of endocrinology.

Recurrence of hyperprolactinaemia following discontinuation of dopamine agonist therapy in patients with prolactinoma occurs commonly especially in macroprolactinoma

T. Barber, J. Wass, J. Byrne, 2011, Clinical endocrinology.

Acute and long-term effects of once-daily oral bromocriptine and a new long-acting non-ergot dopamine agonist, quinagolide, in the treatment of hyperprolactinemia: a double-blind study.

A. Grossman, J. Wass, G. Besser, 1991, Acta endocrinologica.

The effect of the menopause on prolactin levels in patients with hyperprolactinaemia

J. Wass, R. Page, S. Karunakaran, 2001, Clinical endocrinology.

Pituitary Tumours: Recommendations for Service Provision and Guidelines for Management of Patients

R. Clayton, J. Wass, 1998, Eye.

Pituitary tumours in the elderly: a 20 year experience.

J. Wass, H. Turner, C. Adams, 1999, European journal of endocrinology.

Bromocriptine in management of large pituitary tumours.

W. Mcdonald, A. Halliday, J. Wass, 1982, British medical journal.

Aggressive pituitary tumours: the role of temozolomide and the assessment of MGMT status

A. Grossman, J. Wass, A. McCormack, 2011, European journal of clinical investigation.

Proliferation, bcl-2 expression and angiogenesis in pituitary adenomas: relationship to tumour behaviour

A. Harris, M. Esiri, Z. Nagy, 2000, British Journal of Cancer.

The insulin-like growth factors and their binding proteins in a case of non-islet-cell tumour-associated hypoglycaemia.

J. Holly, J. Wass, A. Cotterill, 1991, The Journal of endocrinology.

Absence of uterine neoplasia in patients on bromocriptine.

M. Thorner, J. Wass, G. Besser, 1977, British medical journal.

Identification of Expression Signatures Predictive of Sensitivity to the Bcl-2 Family Member Inhibitor ABT-263 in Small Cell Lung Carcinoma and Leukemia/Lymphoma Cell Lines

Viswanath Devanarayan, Saul H. Rosenberg, Paul E. Kroeger, 2010, Molecular Cancer Therapeutics.

The cortisol stress response induced by surgery: A systematic review and meta‐analysis

Fares Alahdab, J. Lord, M. Murad, 2018, Clinical endocrinology.

Diagnostic and therapeutic review of cystic parathyroid lesions

J. Wass, G. Krassas, A. Cheva, 2012, Hormones.

The tale in evolution: clarity, consistency and consultation, not contradiction and confusion

F. Casanueva, S. Melmed, M. Fleseriu, 2020, Pituitary.

A tale of pituitary adenomas: to NET or not to NET

F. Casanueva, S. Melmed, M. Fleseriu, 2019, Pituitary.

Association of the TSHR gene with Graves' disease: the first disease specific locus

J. Connell, J. Franklyn, S. Gough, 2005, European Journal of Human Genetics.

Quantitative Bacteriology of the Seminal Fluid in Health and Disease

J. Wass, M. Wilks, S. Tabaqchali, 1990 .

The insulin-like growth factor (IGF)-binding proteins and IGF bioactivity in Laron-type dwarfism.

M. Preece, J. Holly, J. Wass, 1992, The Journal of clinical endocrinology and metabolism.

Pituitary disorders in pregnancy

N. Karavitaki, J. Wass, A. Chrisoulidou, 2015, Hormones.

EFFECTS OF LUTEINIZING HORMONE, INSULIN, INSULIN‐LIKE GROWTH FACTOR‐I AND INSULINLIKE GROWTH FACTOR SMALL BINDING PROTEIN 1 IN THE POLYCYSTIC OVARY SYNDROME

G. Conway, J. Wass, H. Jacobs, 1990, Clinical endocrinology.

Hypothalamic Regulating Hormones

J. Wass, G. Besser, 1983 .

Heat-shock gene expression and cell cycle changes during mammalian embryonic development.

M. Edwards, A. Dolnikov, J. Wass, 1993, Developmental genetics.

SOMATOSTATIN SECRETION BY LUNG AND THYMIC TUMOURS

J. Wass, G. Besser, L. Rees, 1980, Clinical endocrinology.

Relationship between E23K (an established type II diabetes-susceptibility variant within KCNJ11), polycystic ovary syndrome and androgen levels

M. McCarthy, E. Zeggini, M. Weedon, 2007, European Journal of Human Genetics.

Ultrasound-guided percutaneous fine needle puncture of the gallbladder for studies of bile composition.

S. Pereira, J. Wass, R. Dowling, 1995, The British journal of radiology.

UK guidelines for the management of pituitary apoplexy

G. Plant, M. Vanderpump, S. Sinha, 2011, Clinical endocrinology.

Hypopituitarism following envenoming by Russell's vipers (Daboia siamensis and D. russelii) resembling Sheehan's syndrome: first case report from Sri Lanka, a review of the literature and recommendations for endocrine management.

D. Warrell, J. Wass, H. Rajaratnam, 2011, QJM : monthly journal of the Association of Physicians.

Granulation pattern, but not GSP or GHR mutation, is associated with clinical characteristics in somatostatin-naive patients with somatotroph adenomas.

N. Karavitaki, J. Wass, S. Cudlip, 2013, European journal of endocrinology.

Growth hormone and memory.

J. Wass, R. Reddy, 2010, The Journal of endocrinology.

Angiogenesis in Prolactinomas: Regulation and Relationship with Tumour Behaviour

J. Wass, H. Turner, N. D. L. Torre, 2005, Pituitary.

Morphologic changes and molecular regulation of angiogenesis in pituitary adenomas.

J. Wass, H. Turner, N. G. de la Torre, 2004, Frontiers of hormone research.

Metabolic syndrome in polycystic ovary syndrome.

M. McCarthy, S. Franks, T. Barber, 2007, Endokrynologia Polska.

Antiangiogenic effects of somatostatin analogues

J. Wass, H. Turner, N. G. de la Torre, 2002, Clinical endocrinology.

Genetic Analyses in a Sample of Individuals With High or Low BMD Shows Association With Multiple Wnt Pathway Genes

M. Brown, J. Eisman, A. Sims, 2007, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Disparate genetic influences on polycystic ovary syndrome (PCOS) and type 2 diabetes revealed by a lack of association between common variants within the TCF7L2 gene and PCOS

P. Elliott, M. McCarthy, E. Zeggini, 2007, Diabetologia.

Significant Benefits of AIP Testing and Clinical Screening in Familial Isolated and Young-onset Pituitary Tumors

Julian R. E. Davis, H. Randeva, R. Eeles, 2020, The Journal of clinical endocrinology and metabolism.

ENDOCRINOLOGY IN THE TIME OF COVID-19-2021 UPDATES: The management of diabetes insipidus and hyponatraemia

E. Hoorn, M. Christ-Crain, C. Thompson, 2021, European journal of endocrinology.

ENDOCRINOLOGY IN THE TIME OF COVID-19: Management of diabetes insipidus and hyponatraemia

E. Hoorn, M. Christ-Crain, C. Thompson, 2020, European Journal of Endocrinology.

Central diabetes insipidus from a patient's perspective: management, psychological co-morbidities, and renaming of the condition: results from an international web-based survey.

L. Hemkens, J. Verbalis, M. Christ-Crain, 2022, The lancet. Diabetes & endocrinology.

Impact of month of birth on the development of autoimmune thyroid disease in the United Kingdom and Europe.

J. Connell, J. Franklyn, M. Simmonds, 2014, The Journal of clinical endocrinology and metabolism.

FAMILIAL ACROMEGALY: STUDIES IN THREE FAMILIES

K. Noonan, J. Wass, J. Monson, 1990, Clinical endocrinology.

Adrenocorticotrophin‐independent unilateral macronodular adrenal hyperplasia occurring with myelolipoma: an unusual cause of Cushing's syndrome

R. Reznek, J. Wass, S. Chew, 1994, Clinical endocrinology.

Angiogenesis and lymphangiogenesis in parathyroid proliferative lesions.

N. García de la Torre, J. Wass, H. Turner, 2004, The Journal of clinical endocrinology and metabolism.

How to avoid precipitating an acute adrenal crisis

J. Wass, W. Arlt, 2012, BMJ : British Medical Journal.

Association of the thyroid stimulating hormone receptor gene (TSHR) with Graves' disease.

J. Barrett, J. Connell, J. Franklyn, 2009, Human molecular genetics.

Loci for regulation of bone mineral density in men and women identified by genome wide linkage scan: the FAMOS study.

A. Uitterlinden, L. Cardon, C. Cooper, 2005, Human molecular genetics.

Angiogenesis in pituitary adenomas - relationship to endocrine function, treatment and outcome.

A. Harris, M. Esiri, Z. Nagy, 2000, Journal of Endocrinology.

Nurturing tomorrow's clinician scientists

J. Tooke, J. Wass, 2013, The Lancet.

Shaping academic medicine

R. Horton, J. Tooke, J. Wass, 2014, The Lancet.

Diagnosis and management of prolactinomas and non-functioning pituitary adenomas

N. Karavitaki, J. Wass, A. Rogers, 2014, BMJ : British Medical Journal.

Gall stones induced by octreotide.

H. Dowling, J. Wass, P. Fairclough, 1992, BMJ.

Nelson syndrome: definition and management.

T. Barber, J. Wass, E. Adams, 2014, Handbook of clinical neurology.

The effects of transsphenoidal surgery on endocrine function and visual fields in patients with functionless pituitary tumours.

P. Coates, A. Grossman, P. Harris, 1989, The Quarterly journal of medicine.

Craniopharyngiomas. Historical aspects of their management

N. Karavitaki, J. Wass, E. Roderick, 2008, Hormones.

Effects of GH on cognitive function in elderly patients with adult-onset GH deficiency: a placebo-controlled 12-month study.

A. Harris, P. Maruff, M. Falleti, 2007, European journal of endocrinology.

The European Registry on Cushing's syndrome: 2-year experience. Baseline demographic and clinical characteristics.

Miklós Tóth, P. Chanson, A. Tabarin, 2011, European journal of endocrinology.

Nonfunctioning and Gonadotrophin-Secreting Adenomas

N. Karavitaki, J. Wass, 2017 .

The postoperative monitoring of nonfunctioning pituitary adenomas

N. Karavitaki, J. Wass, R. Reddy, 2011, Nature Reviews Endocrinology.

Lymphocytic hypophysitis: unusual features of a rare disorder

S. Chew, D. Lowe, P. Jenkins, 1995, Clinical endocrinology.

Non‐functioning pituitary adenomas with positive immunoreactivity for ACTH behave more aggressively than ACTH immunonegative tumours but do not recur more frequently

J. Wass, H. Turner, K. Bradley, 2003, Clinical endocrinology.

Pituitary apoplexy in non‐functioning pituitary adenomas: long term follow up is important because of significant numbers of tumour recurrences

James V. Byrne, Niki Karavitaki, Aparna Pal, 2011, Clinical endocrinology.

Acromegaly and anaplastic astrocytoma: coincidence or pathophysiological relation?

Alberto Fernández, N. Karavitaki, J. Wass, 2007, Pituitary.

Epidemiology, clinical presentation and diagnosis of non-functioning pituitary adenomas

J. Wass, G. Ntali, 2018, Pituitary.

EFFECTS OF THE H2 RECEPTOR ANTAGONIST CIMETIDINE ON PITUITARY HORMONES IN MAN

G. Delitala, W. Stubbs, J. Wass, 1979, Clinical endocrinology.

Late diagnosis of pituitary and parapituitary lesions causing visual failure.

J. Wass, G. Besser, K. P. Moore, 1986, British medical journal.

SOCIETY FOR ENDOCRINOLOGY CLINICAL GUIDANCE: Inpatient management of cranial diabetes insipidus

J. Wass, H. Gleeson, A. Brooke, 2018, Endocrine connections.

Response to Letter to the Editor: “Prevention of Adrenal Crisis: Cortisol Response to Major Stress Compared to Stress Dose Hydrocortisone Delivery”

D. Annane, J. Lord, B. Keevil, 2020, The Journal of clinical endocrinology and metabolism.

Increased Infection Risk in Addison’s Disease and Congenital Adrenal Hyperplasia

K. Toulis, N. Reddy, J. Wass, 2019, The Journal of clinical endocrinology and metabolism.

Oxford Handbook of Endocrinology and Diabetes

J. Wass, H. Turner, John A. H. Wass, 2002 .

SOCIETY FOR ENDOCRINOLOGY ENDOCRINE EMERGENCY GUIDANCE: Emergency management of pituitary apoplexy in adult patients

G. Plant, M. Vanderpump, S. Sinha, 2016, Endocrine connections.

Outcome of transsphenoidal surgery for acromegaly using strict criteria for surgical cure

A. Grossman, A. Grossman, R. Sheaves, 1996, Clinical endocrinology.

Mortality in patients with non-functioning pituitary adenoma is increased: systematic analysis of 546 cases with long follow-up.

A. Grossman, N. Karavitaki, J. Wass, 2015, European journal of endocrinology.

ENDOCRINOLOGY IN THE TIME OF COVID-19: Management of diabetes insipidus and hyponatraemia

E. Hoorn, M. Christ-Crain, C. Thompson, 2020, European journal of endocrinology.

Increased Infection Risk in Addison’s Disease and Congenital Adrenal Hyperplasia

K. Toulis, N. Reddy, J. Wass, 2019, bioRxiv.

Current treatment protocols can offer a normal or near‐normal quality of life in the majority of patients with non‐functioning pituitary adenomas

A. Grossman, Alberto Fernández, N. Karavitaki, 2013, Clinical endocrinology.

Does hypopituitarism recover when macroprolactinomas are treated with cabergoline?

N. Karavitaki, J. Wass, J. Byrne, 2013, Clinical endocrinology.

Origin 7.0

J. Wass, 2002 .

HYPERPROLACTINAEMIA AND MICROADENOMAS IN PRIMARY HYPOTHYROIDISM

J. Wass, G. Besser, R. Touzel, 1987, Clinical endocrinology.

Males with prolactinoma are at increased risk of incident cardiovascular disease

K. Toulis, N. Reddy, K. Cheng, 2018, Clinical endocrinology.

Pituitary Neoplasm Nomenclature Workshop: Does Adenoma Stand the Test of Time?

P. Chanson, S. Radovick, A. Mamelak, 2021, Journal of the Endocrine Society.

Growth hormone releasing factor: comparison of two analogues and demonstration of hypothalamic defect in growth hormone release after radiotherapy.

A. Grossman, M. Savage, D. Coy, 1984, British medical journal.

Systematic dose‐extension of octreotide LAR: the importance of individual tailoring of treatment in patients with acromegaly

J. Wass, H. Turner, V. Thornton-Jones, 2004, Clinical endocrinology.

External Radiation Therapy of Acromegaly

S. Corsello, J. Wass, N. Plowman, 1988 .

Pituitary apoplexy: diagnosis and management

J. Wass, 2014 .

Bromocriptine in the medical management of acromegaly.

M. Thorner, J. Wass, G. Besser, 1980, Advances in biochemical psychopharmacology.

Serial imaging in macroprolactinomas: for how long?

N. Karavitaki, J. Wass, J. Byrne, 2009 .

Treatment of prolactinomas with megavoltage radiotherapy.

A. Grossman, J. Wass, B. Cohen, 1984, British medical journal.

An objective scoring tool in the management of patients with pituitary apoplexy

M. Vanderpump, N. Reddy, W. Drake, 2011, Clinical endocrinology.

Bombesin-like immunoreactivity in human gastrointestinal tract

J. Wass, L. Rees, J. Wass, 1984, Regulatory Peptides.

CHANGES IN CIRCULATING SOMATOMEDIN‐C LEVELS IN BROMOCRIPTINE‐TREATED ACROMEGALY

D. Clemmons, J. Wass, G. Besser, 1982, Clinical endocrinology.

Hypoparathyroidism and coeliac disease: a potentially dangerous combination

J. Wass, Sibylle Kohler, 2009, Journal of the Royal Society of Medicine.

A thyroxine absorption test followed by weekly thyroxine administration: a method to assess non-adherence to treatment.

J. N. Walker, V. Ibbotson, A. Weetman, 2013, European journal of endocrinology.

Acromegaly, colonic polyps and carcinoma

T. Richards, M. Besser, P. Jenkins, 1997, Clinical endocrinology.

Biphosphonate-induced osteonecrosis of the jaws: CT and MRI spectrum of findings in 32 patients.

J. Wass, 2008, Clinical radiology.

An account of the quality of life of patients after treatment for non‐functioning pituitary tumours

M. Hammersley, J. Wass, R. Page, 1997, Clinical endocrinology.

Can we ever stop imaging in surgically treated and radiotherapy-naive patients with non-functioning pituitary adenoma?

N. Karavitaki, J. Wass, J. Byrne, 2010, European journal of endocrinology.

Visual field improvement induced by bromocriptine treatment.

A. Grossman, J. Wass, G. Besser, 1987, Clinical endocrinology.

Impact of musculoskeletal disease on quality of life in long-standing acromegaly.

H. Doll, J. Wass, J. David, 2008, European journal of endocrinology.

Acromegaly: treatment after 100 years.

J. Wass, 1993, BMJ.

Pituitary surgery for acromegaly

R. Clayton, J. Wass, P. Stewart, 1999, BMJ.

Renal failure, glomerular disease and diabetes mellitus.

P. Watkins, J. Wass, V. Parsons, 1978, Nephron.

Proceedings of the discussion, "Tolerability and safety of Sandostatin".

J. Chayvialle, J. Wass, V. Popović, 1992, Metabolism: clinical and experimental.

The enhanced peroxidase one step method increases sensitivity for detection of Ki-67 in pituitary tumours.

M. Esiri, Z. Nagy, J. Wass, 1999, Journal of clinical pathology.

Octreotide treatment of acromegaly. Discussion

J. Wass, Glaser, Belchetz, 1990 .

Octreotide treatment of acromegaly.

J. Wass, 1990, Hormone research.

Opioid induced hypogonadism

N. Karavitaki, J. Wass, R. Reddy, 2010, BMJ : British Medical Journal.

SUCCESSFUL TREATMENT BY CHEMOTHERAPY FOR ACROMEGALY ASSOCIATED WITH ECTOPIC GROWTH HORMONE RELEASING HORMONE SECRETION FROM A CARCINOID TUMOUR

P. Harris, J. Wass, G. Besser, 1990, Clinical endocrinology.

Characterisation by high performance liquid chromatography of circulating growth hormone releasing factors in a human plasma.

J. Wass, G. Besser, L. Rees, 1985, Journal of Endocrinology.

Site and Gender Specificity of Inheritance of Bone Mineral Density

L. Cardon, J. Sinsheimer, E. Duncan, 2003, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Liothyronine cost and prescriptions in England.

P. Taylor, C. Dayan, K. Boelaert, 2019, The lancet. Diabetes & endocrinology.

Molecular Pathology Shows p16 Methylation in Nonadenomatous Pituitaries from Patients with Cushing’s Disease

M. Esiri, W. Farrell, R. Clayton, 2004, Clinical Cancer Research.

Differing effects on gall-bladder motility of lanreotide SR and octreotide LAR for treatment of acromegaly.

J. Wass, A. Thillainayagam, H. Turner, 1999, European journal of endocrinology.

New Treatments for Acromegaly

J. Wass, M. Sheppard, 1998, Journal of the Royal College of Physicians of London.

Gall stones and treatment with octreotide for acromegaly

J. Wass, R. Dowling, G. Besser, 1989, BMJ.

Abnormal growth hormone release in response to human pancreatic growth hormone releasing factor in acromegaly.

A. Grossman, M. Savage, J. Wass, 1983, British medical journal.

University of Birmingham Epidemiology of Acromegaly: Review of population studies

N. Karavitaki, J. Wass, Aikaterini Lavrentaki, 2016 .

History of Prolactin Disorders

J. Wass, John AH Wass, 2019, Prolactin Disorders.

Observations on the hiding behaviour of farmed red deer (Cervus elaphus) calves

J. C. Pollard, R. Littlejohn, J. Wass, 2004 .

Cyclic prednisolone therapy for male infertility associated with autoantibodies to spermatozoa.

J. Wass, L. Hughes, W. Hendry, 1986, Fertility and sterility.

Action on obesity: comprehensive care for all.

J. Wass, N. Finer, 2013, Clinical medicine.

The presence of cation‐dependent proteases for insulin‐like growth factor binding proteins does not alter the size distribution of insulin‐like growth factors in pregnancy

T. Chard, J. Holly, A. Cotterill, 1991, Clinical endocrinology.

Correction to: Criteria for the definition of Pituitary Tumor Centers of Excellence (PTCOE): A Pituitary Society Statement

E. Laws, F. Casanueva, M. Buchfelder, 2018, Pituitary.

Growth hormone, insulin-like growth factor-I and its binding proteins in the follow-up of acromegaly.

J. Wass, 1997, The Journal of endocrinology.

‘Sink or swim’: an evaluation of the clinical characteristics of individuals with high bone mass

E. McCloskey, G. Davey-Smith, E. Duncan, 2011, Osteoporosis International.

Growth hormone neuroregulation and the clinical relevance of somatostatin.

J. Wass, 1983, Clinics in endocrinology and metabolism.

Influence of LRP5 Polymorphisms on Normal Variation in BMD

A. Uitterlinden, M. Brown, C. Cooper, 2004, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Long-term effects of radiotherapy for acromegaly on circulating prolactin.

S. Corsello, J. Wass, G. Besser, 1989, Acta endocrinologica.

Nutrient sensitivity of gastric emptying of digesta in the preruminant calf

J. Wass, C. Girard, F. Bell, 1988, British Journal of Nutrition.

Royal College of Physicians’ flagship conference

J. Wass, 2013, The Lancet.

Risedronate in adults with osteogenesis imperfecta type I: increased bone mineral density and decreased bone turnover, but high fracture rate persists

L. Bradbury, E. Duncan, S. Stuckey, 2011, Osteoporosis International.

PTHR1 Polymorphisms Influence BMD Variation through Effects on the Growing Skeleton

A. Uitterlinden, M. Brown, C. Cooper, 2007, Calcified Tissue International.

Bromocriptine in acromegaly.

A. Liuzzi, M. Thorner, J. Wass, 1981, The New England journal of medicine.

Ketamine-methoxyflurane anesthesia for rabbits.

J. Wass, J. R. Keene, H. M. Kaplan, 1974, American Journal of Veterinary Research.

A comparison of the calving behaviour of farmed adult and yearling red deer (Cervus elaphus) hinds

J. C. Pollard, R. Littlejohn, J. Wass, 2003 .

Lipids and coronary heart disease

J. Wass, H. Turner, 2001 .

DECREASED SEX HORMONE BINDING GLOBULIN (SHBG) AND INSULIN‐LIKE GROWTH FACTOR BINDING PROTEIN (IGFBP‐1) IN EXTREME OBESITY

K. Noonan, P. Kopelman, J. Weaver, 1990, Clinical endocrinology.

Congenital adrenal hyperplasia (CAH) in adults

J. Wass, H. Turner, 2009 .

Changing the name of diabetes insipidus: a position statement of The Working Group for Renaming Diabetes Insipidus.

J. Verbalis, M. Christ-Crain, M. Gurnell, 2022, European journal of endocrinology.

The Effects of Maternal Endocrine Disease on the Fetus and Neonate

J. Wass, 1984 .

Localization of neuroendocrine tumours and insulinomas using radiolabeled somatostatin analogues, 123 I‐Try3‐octreotide and 111in‐pentatreitide

A. Grossman, J. Wass, K. Britton, 1993, Clinical endocrinology.

Hyperandrogenism, Polycystic Ovarian Disease

J. Wass, M. Sathiavageeswaran, 2002 .

Splanchnic and Hepatic Metabolism of Somatostatin: A Study in Cirrhotic Patients with a Portacaval Shunt

R. Gomis, J. Rodés, J. Bosch, 2007, Hepatology.

Response to Letter to the Editor from Chee et al: “Prevention of Adrenal Crisis: Cortisol Response to Major Stress Compared to Stress Dose Hydrocortisone Delivery”

D. Annane, J. Lord, B. Keevil, 2020, The Journal of clinical endocrinology and metabolism.

Growth hormone (GH) replacement therapy in adults

J. Wass, H. Turner, 2009 .

Specimen integrity and statistics: two essential components of good veterinary practice.

J. Wass, 2009, Veterinary journal.

The development and characterization of an eluted stain assay (ESTA) for the insulin-like growth factors.

N. J. Marshall, J. Holly, J. Wass, 1993, Growth regulation.

Clinical Neuroendocrine Relationships in Normal and Disordered Prolactin Secretion

M. Thorner, G. Delitala, W. Stubbs, 1979 .

Growth of three established cell lines on glass microcarriers

M. Dame, J. Wass, James Carani, 1983, Biotechnology and bioengineering.

Ghrelin is reduced in women with polycystic ovary syndrome and correlates inversely with HOMA IR and testosterone

M. McCarthy, F. Casanueva, S. Franks, 2007 .

Cyclosporin for central nervous system sarcoidosis.

S. Chew, J. Wass, J. Wass, 1988, The American journal of medicine.

Renal excretion of fluoride in renal failure and after renal transplantation.

J. Wass, A. A. Choudhury, V. Parsons, 1975, British medical journal.

The medical management of hormone-secreting tumors of the pituitary.

J. Wass, G. Besser, 1983, Annual review of medicine.

Commissioning guidance for weight assessment and management in adults and children with severe complex obesity

R. Viner, J. Dixon, R. Welbourn, 2018, Obesity reviews : an official journal of the International Association for the Study of Obesity.

DOPAMINE AND INHIBITION OF PROLACTIN AND GROWTH-HORMONE SECRETION

M. Thorner, J. Wass, G. Besser, 1976, The Lancet.

A Further Step in Experimental Design (III): The Response Surface

John A. Wass, J. Wass, 2011 .

Treatment of adrenocorticotropin-dependent Cushing's syndrome: a consensus statement.

L. Nieman, J. Bertherat, X. Bertagna, 2008, The Journal of clinical endocrinology and metabolism.

Endocrine effects of nasal continuous positive airway pressure in male patients with obstructive sleep apnoea

J. Stradling, R. Davies, R. Mullins, 2003, Journal of internal medicine.

Surgical debulking of pituitary macroadenomas causing acromegaly improves control by lanreotide

N. Karavitaki, J. Wass, J. Byrne, 2008, Clinical endocrinology.

Acromegaly or chronic renal failure: a diagnostic dilemma

M. Dattani, J. Ahlquist, J. Wass, 1997, Clinical endocrinology.

Nonsurgical cerebrospinal fluid rhinorrhea in invasive macroprolactinoma: incidence, radiological, and clinicopathological features.

J. Wass, J. Byrne, S. Cudlip, 2007, The Journal of clinical endocrinology and metabolism.

Collision lesions of the sella: co-existence of craniopharyngioma with gonadotroph adenoma and of Rathke’s cleft cyst with corticotroph adenoma

B. Scheithauer, N. Karavitaki, J. Wass, 2007, Pituitary.

Nelson's syndrome.

T. Barber, N. Karavitaki, J. Wass, 2010, European journal of endocrinology.

Acute falciparum malaria and parathyroid function

N. Karavitaki, J. Wass, A. Pal, 2007 .

Pilot study to define criteria for Pituitary Tumors Centers of Excellence (PTCOE): results of an audit of leading international centers

S. Melmed, M. Gadelha, L. Nachtigall, 2023, Pituitary.

Acromegaly--results of long term treatment with bromocriptine.

M. Thorner, J. Wass, G. Besser, 1978, Acta endocrinologica. Supplementum.

Bromocriptine and endocrine disorders.

M. Thorner, J. Wass, W. Evans, 1979, Annals of Internal Medicine.

Insulin-like growth factors; autocrine, paracrine or endocrine?

J. Holly, J. Wass, 1989 .

Clinical Endocrine Oncology

I. Hay, J. Wass, 1997 .

Growth hormone and memory.

J. Wass, R. Reddy, 2010, The Journal of endocrinology.

122 Cardiac Abnormalities are Common in Patients Diagnosed with Phaeochromocytoma as Detected by Cardiovascular Magnetic Resonance Imaging

J. Francis, S. Piechnik, S. Neubauer, 2014, Heart.

Impact of month of birth on the development of autoimmune thyroid disease in the United Kingdom and Europe.

J. Connell, J. Franklyn, M. Simmonds, 2014, The Journal of clinical endocrinology and metabolism.

Diagnosis and treatment of hyperprolactinemia: an Endocrine Society clinical practice guideline.

A. Hoffman, V. Montori, F. Casanueva, 2011, The Journal of clinical endocrinology and metabolism.

Valvular heart disease and the use of cabergoline for the treatment of prolactinoma

C. Szmigielski, H. Becher, N. Herring, 2009, Clinical endocrinology.

Mortality in Cushing's syndrome: systematic analysis of a large series with prolonged follow-up.

A. Grossman, N. Karavitaki, J. Wass, 2013, European journal of endocrinology.

Home administration of lanreotide Autogel® by patients with acromegaly, or their partners, is safe and effective

Julian R. E. Davis, H. Randeva, S. Atkin, 2008, Clinical endocrinology.

Recurrence of hyperprolactinaemia following discontinuation of dopamine agonist therapy in patients with prolactinoma occurs commonly especially in macroprolactinoma

T. Barber, J. Wass, J. Byrne, 2011, Clinical endocrinology.

High prevalence of pituitary adenomas: a cross-sectional study in the city of Banbury (Oxfordshire)

Alberto Fernández, N. Karavitaki, J. Wass, 2008 .

Metabolic syndrome in polycystic ovary syndrome.

S. Franks, T. Barber, J. Wass, 2007, Endokrynologia Polska.

Medical Management of Acromegaly with Bromocriptine Effects of Continuous Treatment for Over Three Years

J. Wass, G. Besser, 1978, The Medical journal of Australia.

COMPARISON OF LONG‐ACTING ANALOGUES OF LUTEINIZING HORMONE RELEASING HORMONE IN MAN

A. Kastin, D. Coy, J. Wass, 1979, Clinical endocrinology.

Bromocriptine in management of large pituitary tumours.

W. Mcdonald, J. Wass, G. Besser, 1982, British medical journal.

Hypopituitarism: growth hormone and corticotropin deficiency.

J. Wass, C. Capatina, 2015, Endocrinology and metabolism clinics of North America.

60 YEARS OF NEUROENDOCRINOLOGY: Acromegaly.

J. Wass, C. Capatina, 2015, The Journal of endocrinology.

Guidelines for the management of glucocorticoids during the peri‐operative period for patients with adrenal insufficiency

M. Dattani, A. Vercueil, J. Wass, 2020, Anaesthesia.

Slow intestinal transit and gallstone formation

S. Pereira, J. Wass, R. Dowling, 1993, The Lancet.

When to consider thyroid dysfunction in the neurology clinic

J. Wass, N. Mistry, M. Turner, 2009, Practical Neurology.

Multiple endocrine neoplasia: spectrum of radiologic appearances and discussion of a multitechnique imaging approach.

F. Gleeson, A. Scarsbrook, R. Thakker, 2006, Radiographics.

A study of acromegaly-associated headache with somatostatin analgesia.

M. Korbonits, W. Drake, J. Wass, 2023, Endocrine-related cancer.

Effect of cyclosporin A in male autoimmune infertility.

J. Wass, P. Bouloux, W. Hendry, 1986, Fertility and sterility.

Changing the name of diabetes insipidus: a position statement of The Working Group for Renaming Diabetes Insipidus

J. Verbalis, M. Christ-Crain, M. Gurnell, 2022, Endocrine connections.

Changing the name of diabetes insipidus: a position statement of The Working Group for Renaming Diabetes Insipidus.

J. Verbalis, M. Christ-Crain, M. Gurnell, 2022, Endocrine journal.